AIM: Experimental evidence on the neuromodulatory properties of the Indian resurrection herb 'Selaginella' (a pteridophyte) is limited. Here, we examined the hypothesis that extract of Selaginella delicatula can render protection against 3-nitropropionic acid (3NP)induced oxidative impairments and neurotoxicity. MATERIALS AND METHODS: Mice provided with supplements S. delicatula aqueous extracts (SDAE) orally (400 mg/kg bw/d, 15d) were challenged with 3NP (50 mg/kg bw/d, i.p. from day 11-day 15). RESULTS: Exposure to 3NP induced significant motor deficits, as evidenced by the reduced stride length, increased narrow beam latency and overt behavioral deficits in the open field apparatus. Interestingly, there was a significant delay in the onset and the intensity of neurobehavioral deficits among SDAE prophylactic mice. Biochemical investigation of striatum revealed that SDAE prophylaxis modulated the striatal redox status but also attenuated the 3NP-induced oxidative stress, activity of antioxidant enzymes and mitochondrial complex II. More importantly, AChE activity and dopamine levels were nearly normal among SDAE-mice. CONCLUSION: Collectively, these data suggest that neuroprotection rendered by SDAE prophylaxis may be primarily attributed to the restoration effect on antioxidant defence and mitochondrial function which lead to improved locomotor phenotype. We propose that Selaginella aqueous extracts may provide new perspectives for the development of therapeutic strategies in protecting the brain against oxidative stress-mediated neurodegenerative disorders. , the major contribution factors for the pathophysiology of the disease include excitotoxicity, dopamine toxicity, mitochondrial dysfunction, oxidative stress, apoptosis and autophagy. The process of neurodegeneration can be mimicked in vitro/ in vivo by exposure to various toxins viz., Rotenone, 3-nitro propionic acid (3NP), Paraquat, MPTP, MPP+M 6-OHDA etc [3][4][5] .3NP, a mycotoxin is known to cause significant neurotoxicity predominantly affecting the neurons involved in locomotor behavior in humans and animals. Studies in laboratory animals, suggest that 3NP induces neuronal damage that mainly affects the striatum and mimics most of the histological and neurochemical features of HD [4,6] and hence this phenotypic model is gaining attention as a valuable tool to develop new therapies for HD [4] . The mechanism of 3NP induced neurotoxicity involves inhibition of succinate dehydrogenase (SDH), an enzyme that acts in mitochondrial tricarboxylic acid cycle and the electron transport chain at complex II [7] along with increased oxidative stress, as demonstrated by recent studies leaving scope for use of phytochemicals to reverse the neuronal damage.Although the treatment approaches are limited [1,2] , proposed treatment paradigms generally involve the use of natural antioxidants exhibiting their action by either or combination of speculated processes involving (i) suppression of oxidative/ nitrosative stress (ii) enhancement of mitochondrial function in br...